How much has Eirion Therapeutics raised?
Eirion Therapeutics has raised $40M across 1 round since 2021.
Who invested in Eirion Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Eirion Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$40Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $40MMar 2021
- Investors
- 0
The rounds
- Mar 2021Series A$40M
No investor was named in the report.
Source recorded
Founders and team
From Eirion Therapeutics's own website: 3 on the team.
- Albert HummelDirector
- Barry KurokawaDirector
- Kevin FinneyVice Chairman
Quick answers about Eirion Therapeutics
When did Eirion Therapeutics last raise?
Eirion Therapeutics's most recent round was a Series A of $40M in Mar 2021.
What was Eirion Therapeutics's biggest round?
Its most recent round, $40M in Mar 2021, is also its largest on record.
What stage is Eirion Therapeutics at?
Eirion Therapeutics's latest named round is a Series A, in Mar 2021.
Companies like Eirion Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.